Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
This once weekly subcutaneous injection activates both incretin receptors, producing additive effects that surpass single receptor approaches
For some users, this means two to three loose bowel movements per day during the first week
Insulin Sensitivity and Glucose Control: Boosts NAD+ to improve mitochondrial efficiency and glucose uptake, potentially aiding type 2 diabetes management
J Physiol 559 : 729737 Date Y et al
Your prescribing clinician should be able to address these questions as part of your evaluation
FDA labeling indicates no clinically relevant pharmacokinetic changes across the spectrum of hepatic impairment (Child-Pugh classes A-C), and no dose adjustment is recommended based on hepatic function
US$ 20.66
US$ 28.92
US$ 20.19
